Product Information
METRONIDAZOLE 500 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.1005 per EA under NDC 68001036503. Its NADAC has been published 391 times since Jan 2, 2019.
Strength
500 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001036503
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203458On Market Since
8/1/2018
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 500 MG TABLET has been published 391 times since Jan 2, 2019, and over the history we have for it it has declined 52.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1005 per EA |
|---|---|
| All-time high | $0.2170 (Mar 13, 2019) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1102 |
| 52-week low | $0.0999 |
| Median price | $0.1430 |
| Average price | $0.1401 |
| Largest weekly change | +39.1% (Jun 19, 2024) |
| Weeks tracked | 391 |
| Tracking since | Jan 2, 2019 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 500 MG TABLET, manufactured by BluePoint Laboratories, is $0.1005 per EA (NDC 68001036503), effective Jun 24, 2026.
How has the price of METRONIDAZOLE 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 500 MG TABLET has declined 52.0%. It has been tracked across 391 weekly CMS publications since Jan 2, 2019.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 500 MG TABLET?
Since Jan 2, 2019, the NADAC for METRONIDAZOLE 500 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.2170 (Mar 13, 2019), with a median of $0.1430 per EA.
Are there cheaper alternatives to METRONIDAZOLE 500 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as METRONIDAZOLE 500 MG TABLET, but none are currently priced below it.
Who manufactures METRONIDAZOLE 500 MG TABLET?
METRONIDAZOLE 500 MG TABLET (NDC 68001036503) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification